BJMO - volume 12, issue 7, november 2018
N. van den Eede MD, A. de Paepe MD, D. Strens MSc, P. Specenier MD, PhD
We calculated the management costs from diagnosis to death of glioblastoma patients treated at the Antwerp University Hospital between 2007 and 2016. Overall, the average cost per patient from the health care payer’s perspective was €45,165 (95% confidence interval €37,204–€54,104). The major cost driving factor was hospitalisation.
(BELG J MED ONCOL 2018;12(7):334–338)
Read moreBJMO - volume 12, issue 6, october 2018
P. Specenier MD, PhD
OVERVIEW OF BELGIAN REIMBURSEMENT NEWS
(BELG J MED ONCOL 2018;12(6):301–302)
Read moreBJMO - volume 12, issue 6, october 2018
P. Specenier MD, PhD
Three inhibitors ALK-inhibitors have been assessed in six randomised phase III trials in patients with advanced anaplastic lymphoma kinase (ALK) positive Non Small-Cell Lung Cancer (NSCLC). Patient and tumour characteristics, efficacy, and safety results are summarised in Tables 1, 2, and 3, respectively. Progression-free survival was the primary endpoint in all trials. In first-line, alectinib was superior to crizotonib, and both crizotinib and ceritinib were superior to pemetrexed plus platinum. Crizotinib and ceritinib were superior to pemetrexed or docetaxel in previously treated patients.
(BELG J MED ONCOL 2018;12(6):275–278)
BJMO - volume 12, issue 5, september 2018
P. Specenier MD, PhD
OVERVIEW OF BELGIAN REIMBURSEMENT NEWS
(BELG J MED ONCOL 2018;12(5):263–264)
Read moreBJMO - volume 12, issue 4, august 2018
P. Specenier MD, PhD
This article will summarize the key data in the field of head and neck cancer presented during the 2018 annual meeting of the American Society of Clinical Oncology (ASCO).
Read moreBJMO - volume 12, issue 3, may 2018
P. Specenier MD, PhD
OVERVIEW OF BELGIAN REIMBURSEMENT NEWS
(BELG J MED ONCOL 2018;12(3):145–146)
Read moreBJMO - volume 12, issue 2, march 2018
P. Specenier MD, PhD
Overview of Belgian reimbursement news.
(BELG J MED ONCOL 2018;12(2):86–91)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
